advertisement
Advertisement (image not found)

News

Link Unraveled Between Chromosomal Instability and Centrosome Defects in Cancer Cells

Monday, June 08, 2009

In a new study, Dana-Farber Cancer Institute scientists disprove a century-old theory about why cancer cells often have too many or too few chromosomes, and show that the actual reason may hold the key to a novel approach to cancer therapy.

Source: Dana-Farber Cancer Institute

Breaking News

Syrris Defies the Recession

Syrris, a leading chemistry automation product innovator, has had an exceptionally strong start to 2009...

Friday, July 03, 2009 Source: Syrris Inc.

Triple-Marker Screening Program Shows High Detection Rate for Down Syndrome

The triple-marker prenatal screening program used in California can detect 77.4%...

Friday, July 03, 2009 Source: Reuters Health

C-Section Stress Could Alter Baby's Immune Cells

Babies delivered by cesarean section experience changes to the DNA of white...

Friday, July 03, 2009 Source: HealthDay News

Pharming Group (PHGUF.PK) Confirms Positive Results from Final Analysis of Rhucin(R) Studies

Leiden, The Netherlands, July 1, 2009. Biotech company Pharming Group NV (“Pharming”...

Friday, July 03, 2009 Source: BioSpace.com

Cardioxyl Pharmaceuticals Initiates Phase I/IIa Study in Heart Failure

Cardioxyl Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing...

Friday, July 03, 2009 Source: Marketwire

Provectus Pharmaceuticals Inc. Completes Patient Accrual in Initial Phase 2 Study of PH-10 for Atopic Dermatitis

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology...

Friday, July 03, 2009 Source: BUSINESS WIRE

CHN Elemental Analyzer Designed for University Labs

The Model CE-440 CHN Elemental Analyzer from Exeter Analytical Inc. has established...

Friday, July 03, 2009 Source: Exeter Analytical Inc.

Patent News

Prodesse Announces Licensure of Two Additional Patents

Prodesse Inc., a molecular diagnostics company focused on infectious disease,...

Tuesday, June 30, 2009 Source: Prodesse Inc.

Bion Announces Approval of New U.S. Patent that Broadens Protection for the Company's Livestock Waste Environmental Treatment Processes

Bion Environmental Technologies, Inc. announced today that it was notified that its U.S...

Tuesday, June 30, 2009 Source: Bion Environmental Technologies, Inc.

PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin

PROLOR Biotech, Inc. , formerly Modigene Inc., today announced that the U. S...

Tuesday, June 30, 2009 Source: PROLOR Biotech, Inc.

Clinical Trials News

Pharming Group (PHGUF.PK) Confirms Positive Results from Final Analysis of Rhucin(R) Studies

Leiden, The Netherlands, July 1, 2009. Biotech company Pharming Group NV (“Pharming”...

Friday, July 03, 2009 Source: BioSpace.com

Cardioxyl Pharmaceuticals Initiates Phase I/IIa Study in Heart Failure

Cardioxyl Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing...

Friday, July 03, 2009 Source: Marketwire

Provectus Pharmaceuticals Inc. Completes Patient Accrual in Initial Phase 2 Study of PH-10 for Atopic Dermatitis

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology...

Friday, July 03, 2009 Source: BUSINESS WIRE

News Search

Search News By Keywords
advertisement
Here"s the HTML to use:

You do not have JavaScript enabled or are using an older version of Adobe Flash. You can update your version of Adobe Flash here.

Email Newsletter Sign-Up

Stay updated on the latest technologies and news with Biocompare's newsletters
(See samples here)









Select All

Loading

Loading